154 related articles for article (PubMed ID: 21962092)
21. Multiple-dose proportionality study of flunisolide hydrofluoroalkane.
Nolting A; Abramowitz W
Allergy Asthma Proc; 2002; 23(5):311-8. PubMed ID: 12476540
[TBL] [Abstract][Full Text] [Related]
22. Effect of HFA-flunisolide on peripheral lung inflammation in asthma.
Hauber HP; Gotfried M; Newman K; Danda R; Servi RJ; Christodoulopoulos P; Hamid Q
J Allergy Clin Immunol; 2003 Jul; 112(1):58-63. PubMed ID: 12847480
[TBL] [Abstract][Full Text] [Related]
23. High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children.
Decimo F; Maiello N; Miraglia Del Giudice M; Amelio R; Capristo C; Capristo AF
Int J Immunopathol Pharmacol; 2009; 22(2):363-70. PubMed ID: 19505390
[TBL] [Abstract][Full Text] [Related]
24. Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma.
Lee-Wong M; Dayrit FM; Kohli AR; Acquah S; Mayo PH
Chest; 2002 Oct; 122(4):1208-13. PubMed ID: 12377843
[TBL] [Abstract][Full Text] [Related]
25. Flunisolide aerosol for treatment of severe, chronic asthma in steroid-independent children.
Meltzer EO; Kemp JP; Orgel HA; Izu AE
Pediatrics; 1982 Mar; 69(3):340-5. PubMed ID: 7063290
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma.
Sheikh S; Goldsmith LJ; Howell L; Eid N
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):300-4. PubMed ID: 10541421
[TBL] [Abstract][Full Text] [Related]
27. The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control.
ZuWallack RL; Rosen JP; Cohen L; Rachelefsky GS; Gong H; Goldsobel AB; Kaliner MA; White MV; Bronsky EA; Chervinsky P; Lotner GZ; Corren J; Bodenheimer S
J Allergy Clin Immunol; 1997 Mar; 99(3):278-85. PubMed ID: 9058681
[TBL] [Abstract][Full Text] [Related]
28. Single-dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide.
Nolting A; Sista S; Abramowitz W
J Pharm Sci; 2002 Feb; 91(2):424-32. PubMed ID: 11835202
[TBL] [Abstract][Full Text] [Related]
29. Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study.
Becker AB; Kuznetsova O; Vermeulen J; Soto-Quiros ME; Young B; Reiss TF; Dass SB; Knorr BA;
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):800-7. PubMed ID: 16802767
[TBL] [Abstract][Full Text] [Related]
30. Inhaled flunisolide for acute severe asthma.
Rodrigo G; Rodrigo C
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):698-703. PubMed ID: 9517578
[TBL] [Abstract][Full Text] [Related]
31. Safety of the newer inhaled corticosteroids in childhood asthma.
Randell TL; Donaghue KC; Ambler GR; Cowell CT; Fitzgerald DA; van Asperen PP
Paediatr Drugs; 2003; 5(7):481-504. PubMed ID: 12837120
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group.
Mellon M
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):191-9. PubMed ID: 10518846
[TBL] [Abstract][Full Text] [Related]
33. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
34. Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group.
Allen DB; Bronsky EA; LaForce CF; Nathan RA; Tinkelman DG; Vandewalker ML; Konig P
J Pediatr; 1998 Mar; 132(3 Pt 1):472-7. PubMed ID: 9544904
[TBL] [Abstract][Full Text] [Related]
35. Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide.
Bergeron C; Hauber HP; Gotfried M; Newman K; Dhanda R; Servi RJ; Ludwig MS; Hamid Q
J Allergy Clin Immunol; 2005 Nov; 116(5):983-9. PubMed ID: 16275364
[TBL] [Abstract][Full Text] [Related]
36. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
Pedersen S; Warner J; Wahn U; Staab D; Le Bourgeois M; Van Essen-Zandvliet E; Arora S; Szefler SJ;
Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
[TBL] [Abstract][Full Text] [Related]
37. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.
Pauwels RA; Pedersen S; Busse WW; Tan WC; Chen YZ; Ohlsson SV; Ullman A; Lamm CJ; O'Byrne PM;
Lancet; 2003 Mar; 361(9363):1071-6. PubMed ID: 12672309
[TBL] [Abstract][Full Text] [Related]
38. Flunisolide aerosol in treatment of steroid-dependent asthma in children.
Orgel HA; Meltzer EO; Kemp JP
Ann Allergy; 1983 Jul; 51(1 Pt 1):21-5. PubMed ID: 6346962
[TBL] [Abstract][Full Text] [Related]
39. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
Jacobson K; Chervinsky P; Noonan M; Kane RE; Banerji D; Uryniak T
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425
[TBL] [Abstract][Full Text] [Related]
40. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
Wolthers OD; Walters EG
Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
